First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Network phase II trial

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 22; no. 14_suppl; p. 643
Main Authors	Yardley, D. A., Greco, F. A., Porter, L. L., Burris, H. A., Phelps, C., Webb, C., Schlabach, L., Fichtel, L. M., Hainsworth, J. D.
Format	Journal Article
Language	English
Published	15.07.2004
Online Access	Get full text

Loading…